Valued at a market cap of $17.4 billion, Tempe, Arizona-based Gen Digital Inc. (GEN) is a global company focused on enabling Digital Freedom through trusted consumer brands including Norton, Avast, LifeLock, and MoneyLion. The company provides products and services spanning cybersecurity, online privacy, identity protection, and financial wellness.
Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Gen Digital fits this criterion perfectly, exceeding the mark. Gen Digital serves nearly 500 million users across more than 150 countries, helping consumers live their digital lives safely, privately, and confidently.
Shares of Gen Digital have dipped 9.9% from its 52-week high of $31.65. The stock has increased 25% over the past three months, outperforming the broader iShares Expanded Tech-Software Sector ETF’s (IGV) return of 22.4% during the same period.
Gen Digital’s shares have risen 5.8% on a YTD basis, outpacing IGV's 1.1% gain. The stock has declined marginally over the past 52 weeks, compared to IGV's 9.3% drop over the same time frame.
GEN stock has been trading above its 50-day moving average since May.
Gen Digital shares rose 3.8% following its Q1 2027 results on Aug. 6 as adjusted revenue increased 11% to $1.34 billion, bookings grew 11% to $1.28 billion, and adjusted EPS jumped 19% to $0.71, reflecting broad-based growth across both segments. The company also generated $430 million in free cash flow and delivered $668 million in adjusted operating income, up 9%, including EPS surged 65% to $0.36.
In addition, Gen Digital raised its fiscal 2027 revenue guidance to $5.38 billion - $5.48 billion and adjusted EPS guidance to $2.87 - $2.97.
In comparison, rival Microsoft Corporation (MSFT) has underperformed GEN stock. Shares of Microsoft have gained 3% on a YTD basis and declined 3.2% over the past 52 weeks.
Despite the stock’s outperformance relative to its industry peers, analysts are cautiously optimistic, with a consensus rating of "Moderate Buy" from 10 analysts. The mean price target of $33.60 suggests a premium of 17.6% to current levels.
